Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
Take Tell Us What YOU Think! Take The Body's Visitor Survey!
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Merck: Price Drop Helps Expand Access to AIDS Drugs

From U.S. Centers for Disease Control and Prevention

November 27, 2001

The number of people in poor countries taking Merck & Co.'s AIDS drugs has grown 40 percent to 70,000 since the company began selling its medicines at cost to those nations nine months ago. Still, that number, announced Monday, is only a fraction of those who need to be taking the medicine, said an advisor with Doctors Without Borders. For example, sub-Saharan Africa, home to 25 million infected with AIDS, has been hardest hit by the pandemic. About 2.5 million to 3 million there should be taking medicines, but only 25,000 to 30,000 are on any type of therapy, said Doctors Without Borders medical advisor Anne-Valerie Kaninda.


Back to other CDC news for November 27, 2001

Previous Updates

Adapted from:
Associated Press
11.27.01; Theresa Agovino

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
 

Advertisement